AgraFlora Organics International Inc.’s (OTMKTS:PUFXF) Using Proprietary Manufacturing Processes For CBD-Infused Formulations In Toronto Facility

AgraFlora Organics International Inc. (OTCMKTS:PUFXF) has provided guidance regarding the integration of its proprietary CBD formulations collection and manufacturing processes at its GMP-certified facility in Toronto.

AgraFlora formulations have 99% THC potency

The company has indicated that the on-going integration of the manufacturing equipment at the GMP-certified Toronto facility is being customized to support the company’s proprietary micro-diffusion technologies hence optimizing the bioavailability and solubility of CBD products. the company’s CBD formulation catalogue has already been deployed successfully across dispensaries in in Colorado. The formulations’ have a THC potency of around 99% which exceeds the domestic standards that require less than 10% potency.

AgraFlora has contracted nutritionists, food engineers and scientists to improve bioavailability and enhance dosing protocols as well as flavouring licensed formulations. The company plans to continue leveraging its processing assets and production as well as further activate its downstream activities through the launch of CBD-infused drinks, personal care products and edibles produced with the micro-diffusion tech.

The company’s in-house science consultancy arm comprises of microbiologists and America Institute of Baking certified bakers. AIB is a renowned institution in quality management and food safety that employs enhanced production practices for leading world food conglomerates such as Nestle, Heinz and Kraft.

The state of the art facility in Toronto

AgraFlora scientists and nutritionist have done so much for various fortune 500 companies having created several turnkey recipes that have resulted in more than $300 million in sales revenue. With close to 3 decades of experience in the CPG food product development industry the company’s in-house development team has created a portfolio of popular products in the industry of companies such as Dean Foods.

Recently the company’s in-house product formulation scientists introduced the scalable formulation of shelf stable CBD/THC-infused edibles in the Colorado market. The company’s Toronto facility is already undergoing necessary licensing in anticipation for the Health Canada topicals, edibles and beverages regulations. The facility has been outfitted with special pharma-grade mixing tanks that have been designed to sustain the high processes need to produce quality brew teas and coffees. The facility is one of the most advanced CBD-infused drinks manufacturing facilities in world.


Agraflora Organics International Inc. (OTCMKTS:PUFXF) Provides Updates On Expansion Initiatives Of The Brunswick Bierworks Facilty

AgraFlora Organics International Inc. (OTCMKTS:PUFXF) has provided operational guidance as well as retrofit updates regarding the current expansion initiatives of the Brunswick Bierworks facility that is located in Toronto. 

Expansion initiative to increase production to 130,000 hl

The expansion initiative involves an increase of the annual production capacity to around 130,000 hectolitres which is a 305 increase of the previous maximum capacity. The initiative also involves access to more off-site alternative brewing capacity and the installation of a CBD-infused drink packaging line that has four, six and twelve can capability.

The company expects to commence product formulation and batch testing as from Q3 2019 with commercial production expected to begin in Q4 2019. There is planned development of a CBD-infused tasting facility.  AgraFlora has a partnership agreement with renowned Canadian brewing Brunswick Bierworks and it holds exclusive formulation, production, and distribution rights of CBD infused drinks manufactured at Brunswick’s Brewhouse in Toronto Ontario.

The company and Brunswick Bierworks are expected to continue pursuing aggressively the expansion initiatives at the ultra-modern Brewhouse. Once the expansion of the facility retrofit is completed the total capital expenditures used on the Brewhouse will be in excess of C$20 million. The Brewhouse that is composed of a group of experienced brewery associates has so far completed a number of production runs for renowned European beverage brands like Augustiner, Guinness and Inner & Gunn.

AgraFlora to leverage Brunswick Bierworks’ proprietary processing technology

The partnership between AgraFlora and the Brewhouse put it on the forefront of the CBD beverage industry in Canada because of the proprietary processing technology of the Brewhouse that makes it suitable for the development of CBD-infused and non-alcoholic drinks.

AgraFlora CEO Brandon Boddy stated that the company’s partnership with Brunswick Bierworks will help in cementing the company’s position in the CBD-infused drinks sector in Canada. The company is looking forward to the legalization of cannabis beverages and edibles in Canada later this year and the partnership solidifies AgraFlora’s brewing infrastructure distribution relationships and product development that is necessary for attaining greater market share.


Agraflora Organics International Inc (OTCMKTS:PUFXF) Acquires Manitoba Based Edibles Manufacturing Facility And Expects To Generate Annual Revenues Of Over $750 Million In 2020

Edibles And Infusions Corp (EIC), a subsidiary of Agraflora Organics International Inc (OTCMKTS:PUFXF),has taken over Winnipeg, Manitoba based 51,500 Sq. Ft. manufacturing facility. The company expects to complete the facility upgrades such as electrical, mechanical, architectural, and security retrofits by September 2019 and comply with Health Canada regulations. Agraflora has a stake of 80% in EIC.

Revenues of over $750 million

EIC expects to generate revenues of over $750 million per annum when the facility becomes operational in Q1 2020. The company would distribute the products through existing distribution channels in 20,000 locations that comprise Wal-Mart and Costco.

EIC already have several hundred SKUs in production. It benefits from experienced confectioners and chocolatiers, established supply chain management infrastructure, and industry relationships.

Automated manufacturing line

EIC expects delivery of automated depositing and manufacturing line in Q1 2020 for toffee, chocolate, CBD infused gummies, hard candy, and caramel. The company expects the completion of product development and R&D Lab for turnkey and pharmaceutical grade edibles by August 2020.

EIC expects the receipt of sales and processing licenses from Health Canada by Q1 2020. The company would engage cannabis license experts and 3 Sixty Risk Solutions Ltd for expediting applications. It will also use these two firms for developing SOPs (standard operating procedure).

EIC is in advanced negotiations for the development and contract manufacturing of CBD edible confections with Tier 1 licensed producers in Canada. It is also negotiating for securing national listings for cannabidiol infused foods in retail locations and major groceries.

Following the receipt of a license from Health Canada, EIC will engage in the production of terpene and CBD infused products for functional, medicinal and adult use. Its product line comprises caramels, toffees, gummies, gum, baked goods, glazed pecans, cheese biscuits, caramel popcorn, cocoa cookies, salty pretzels, CBD infused pet products, and powdered drinks.

Guidance for AAA Heidelberg facility

Agraflora has issued operating guidance for its wholly owned AAA Heidelberg facility for Q3 2019 to Q4 2020. The company expects to receive an export license, sales license, and processing license from Health Canada. It expects fully optimized production facilities with capabilities of circa 1 million grams of dried craft cannabis flower.

Pin It on Pinterest